Oliver Sartor host Ken Herrmann to discuss tumor dosimetry findings from a VISION trial substudy examining lutetium PSMA therapy in prostate cancer patients. Dr. Herrmann presents data showing that tumor-absorbed dose per injected activity decreases significantly across treatment cycles, with approximately 60% of cumulative absorbed dose occurring in the first two cycles. He explores differences…
More Californians are getting mental health or substance use disorder treatment online or over the phone than in person, according to a KFF Health News…
Ashish Kamat speaks with Marco Moschini about expanding active surveillance criteria for recurrent low-grade bladder cancer. Dr. Moschini presents his single-center retrospective study from San…
The FDA has approved the first blood test for diagnosing Alzheimer’s disease, which could speed the path to treatment for patients
Learn about career opportunities available at Henry Ford Health and why you should come work with us.
More than 70 million U.S. adults live with physical, sensory, cognitive, developmental, or intellectual disabilities. These individuals are more than twice as likely than other…
Sprinter Health’s $55 million Series B round was led by General Catalyst and included participation from Andreessen Horowitz (a16z) Bio + Health, the Regents of…
MPC Members have access to quarterly newsletters that provide seasonal health tips, upcoming events and health screenings. Click here to learn more.
While mRNA-LNPs efficiently transfect lung epithelial and immune cells, they induce poor immunogenicity after primary vaccination. Encouragingly, intranasal mRNA-LNP boosting can efficiently recall immunity in…
Speaking on his executive order about lowering prescription drug prices, President Trump told reporters Monday that Americans will pay “the lowest price in the world.”…
